ASTRO: NSAIDs May Offer Benefit to Head & Neck Cancer Patients
Nonsteroidal anti-inflammatory drugs are correlated with better overall survival in patients with head and neck squamous cell carcinoma, and there is a nonsignificant benefit for aspirin use in non-small cell lung cancer, according to two studies presented at the annual meeting of the American Society for Radiation Oncology, held from Sept. 15 to 19 in Chicago.